Approach to large thrombus burden in ST-elevation myocardial infarction

In ST-Elevation Myocardial Infarction (STEMI), Primary Percutaneous Coronary Intervention (PPCI) is the preferred treatment. However, High Thrombus Burden (HTB), defined by extensive thrombus in the Infarct-Related Artery (IRA), particularly with "cut-off" occlusion patterns and large vessel diameter (>3.5 mm), presents a major challenge. Despite the use of effective anticoagulation, glycoprotein IIb/IIIa inhibitors, and Dual Antiplatelet Therapy (DAPT), HTB remains a significant obstacle. It is associated with complications such as no/slow reflow and distal embolization, leading to adverse cardiovascular outcomes. Accurate assessment using angiographic features and MI thrombus grading is essential before choosing a therapeutic strategy. Management options include mechanical thrombectomy, aspiration, parenteral/oral antiplatelets, intracoronary thrombolytics, and stenting approaches like direct stenting. Success depends on tailored, scenario-specific application of these therapies. This review highlights current strategies to manage HTB during PPCI.

Authors

Institutions

Publication Details

Journal
Frontiers in Cardiovascular Medicine
Published
2026-02-09
DOI
https://doi.org/10.3389/fcvm.2025.1610917
Citations
1
Primary Topic
Acute Myocardial Infarction Research
Type
article
Field-Weighted Citation Impact
30.07
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Approach to large thrombus burden in ST-elevation myocardial infarction

Bhavya Mody, Debabrata Dash, Rajeev Gupta, Umanshi Dash et al.
1 citations
Frontiers in Cardiovascular Medicine
Acute Myocardial Infarction Research
30.07
article

Approach to large thrombus burden in ST-elevation myocardial infarction

Bhavya Mody, Debabrata Dash, Rajeev Gupta, Umanshi Dash, Rohit Mody
article en
1 citations

Abstract

In ST-Elevation Myocardial Infarction (STEMI), Primary Percutaneous Coronary Intervention (PPCI) is the preferred treatment. However, High Thrombus Burden (HTB), defined by extensive thrombus in the Infarct-Related Artery (IRA), particularly with "cut-off" occlusion patterns and large vessel diameter (>3.5 mm), presents a major challenge. Despite the use of effective anticoagulation, glycoprotein IIb/IIIa inhibitors, and Dual Antiplatelet Therapy (DAPT), HTB remains a significant obstacle. It is associated with complications such as no/slow reflow and distal embolization, leading to adverse cardiovascular outcomes. Accurate assessment using angiographic features and MI thrombus grading is essential before choosing a therapeutic strategy. Management options include mechanical thrombectomy, aspiration, parenteral/oral antiplatelets, intracoronary thrombolytics, and stenting approaches like direct stenting. Success depends on tailored, scenario-specific application of these therapies. This review highlights current strategies to manage HTB during PPCI.

Frontiers in Cardiovascular MedicineVol. 12
ASTER (CA), Trinity Health (US), Shree Krishna Hospital (IN), Spectrum Scientific (United States) (US)
Good health and well-being
Openalex Percentile: Top 1%
Acute Myocardial Infarction Research
30.07
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.